Halozyme Therapeutics (HALO) Non-Current Debt (2021 - 2026)
Halozyme Therapeutics (HALO) reported Non-Current Debt of $1.94 billion for Q2 2026, up 28.4% from $1.51 billion a year earlier and up 0.1% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Non-Current Debt (2021 - 2026) Analysis & Trends
At the end of FY2025, Halozyme Therapeutics posted Non-Current Debt of $2.14 billion, up 42.3% from FY2024.
- Non-Current Debt has increased for four consecutive years, with a four-year compound annual growth rate of 28.4% (FY2021 to FY2025).
- By year, Non-Current Debt came in at $1.51 billion in FY2024 (+0.4%), $1.5 billion in FY2023 (+0.4%), $1.49 billion in FY2022 (+89.6%) and $787.26 million in FY2021.
- Five-year quarterly Non-Current Debt spans a low of $787.26 million in Q4 2021 and a high of $2.14 billion in Q4 2025.
- Year over year, Non-Current Debt has now increased in each of the last three quarters, with growth averaging 6.8% over the last eight quarters.
- The high point for year-over-year Non-Current Debt in five years was Q4 2022 (growth of 89.6%); the low point was Q3 2025 (a decline of 46.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.94 billion (Q1 2026), $2.14 billion (Q4 2025) and $800.07 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | - |
| 10 | Halozyme Therapeutics | 12.72 Bn | 11.33 Bn | 401.83 Mn | 1.94 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.94 Bn |
| Mar 31, 2026 | 1.94 Bn |
| Dec 31, 2025 | 2.14 Bn |
| Sep 30, 2025 | 800.07 Mn |
| Jun 30, 2025 | 1.51 Bn |
| Mar 31, 2025 | 1.51 Bn |
| Dec 31, 2024 | 1.51 Bn |
| Sep 30, 2024 | 1.50 Bn |
| Jun 30, 2024 | 1.50 Bn |
| Mar 31, 2024 | 1.50 Bn |
| Dec 31, 2023 | 1.50 Bn |
| Sep 30, 2023 | 1.50 Bn |
| Jun 30, 2023 | 1.50 Bn |
| Mar 31, 2023 | 1.49 Bn |
| Dec 31, 2022 | 1.49 Bn |
| Sep 30, 2022 | 1.49 Bn |
| Dec 31, 2021 | 787.26 Mn |
API Access
Halozyme Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();